- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- May 2024
- 129 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Drug Pipelines
- November 2020
- 40 Pages
Global
From €1909EUR$2,000USD£1,599GBP
Gingivitis is a common form of gum disease caused by the buildup of plaque on the teeth. It is characterized by red, swollen, and bleeding gums. Gingivitis is typically treated with a combination of professional dental cleaning and good oral hygiene. Pharmaceuticals play an important role in the treatment of gingivitis, with a variety of drugs available to help reduce inflammation and prevent further damage to the gums.
Common gingivitis drugs include antibiotics, antiseptics, and anti-inflammatory medications. Antibiotics are used to reduce the number of bacteria in the mouth, while antiseptics help to reduce inflammation and prevent further infection. Anti-inflammatory medications help to reduce swelling and pain associated with gingivitis.
Some of the companies in the gingivitis drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of drugs to treat gingivitis, including antibiotics, antiseptics, and anti-inflammatory medications. Show Less Read more